(VUKE) Vanguard FTSE 100 CHF - Ratings and Ratios
UK Stocks, Large Cap, Equity Funds, Index Tracker, Stocks
Description: VUKE Vanguard FTSE 100 CHF
The Vanguard FTSE100 UCITS ETF CHF is an exchange-traded fund that tracks the Morningstar UK All Cap TME NR GBP index, providing investors with exposure to the UK large-cap equity market. With a total assets under management (AUM) of approximately 3.74 billion CHF, this ETF is a sizable player in the UK equity market.
From a technical analysis perspective, the ETFs price is currently at 41.40 CHF, which is below its 20-day simple moving average (SMA) of 42.18 CHF, indicating a potential short-term downtrend. However, the 50-day SMA at 40.94 CHF and 200-day SMA at 40.21 CHF suggest a longer-term uptrend. The average true range (ATR) is 0.24 CHF, representing a daily price volatility of 0.58%. The ETFs price has fluctuated between a 52-week high of 43.37 CHF and a low of 35.37 CHF.
To further evaluate the ETFs performance, we can consider key performance indicators (KPIs) such as tracking error, expense ratio, and dividend yield. Vanguard is known for its low-cost index funds and ETFs, so its likely that the expense ratio is relatively low. The dividend yield can be estimated based on the underlying indexs dividend yield, which is typically around 4-5% for the FTSE 100 index. A low tracking error would indicate that the ETF is effectively replicating the performance of the underlying index.
Investors should also consider the ETFs liquidity, trading volume, and bid-ask spread when evaluating its investability. A liquid ETF with a tight bid-ask spread can reduce trading costs and minimize the risk of large price movements. By analyzing these KPIs, investors can make a more informed decision about whether the Vanguard FTSE100 UCITS ETF CHF is a suitable investment for their portfolio.
Additional Sources for VUKE ETF
VUKE ETF Overview
Market Cap in USD | 4,725m |
Category | UK Large-Cap Equity |
TER | 0.10% |
IPO / Inception | 2012-05-22 |
VUKE ETF Ratings
Growth Rating | 58.3 |
Fundamental | - |
Dividend Rating | 57.6 |
Rel. Strength | -9.39 |
Analysts | - |
Fair Price Momentum | 40.20 CHF |
Fair Price DCF | - |
VUKE Dividends
Dividend Yield 12m | 3.30% |
Yield on Cost 5y | 4.80% |
Annual Growth 5y | 8.06% |
Payout Consistency | 92.2% |
Payout Ratio | % |
VUKE Growth Ratios
Growth Correlation 3m | 17.8% |
Growth Correlation 12m | 65% |
Growth Correlation 5y | 78.3% |
CAGR 5y | 11.13% |
CAGR/Max DD 5y | 0.49 |
Sharpe Ratio 12m | 0.35 |
Alpha | 6.44 |
Beta | 0.476 |
Volatility | % |
Current Volume | 0k |
Average Volume 20d | 0.6k |
As of July 03, 2025, the stock is trading at CHF 41.13 with a total of 0 shares traded.
Over the past week, the price has changed by -1.08%, over one month by -2.21%, over three months by -2.62% and over the past year by +5.23%.
Partly, yes. Based on ValueRay´s Analyses, Vanguard FTSE 100 CHF (SW:VUKE) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.28 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VUKE is around 40.20 CHF . This means that VUKE is currently overvalued and has a potential downside of -2.26%.
Vanguard FTSE 100 CHF has no consensus analysts rating.
According to our own proprietary Forecast Model, VUKE Vanguard FTSE 100 CHF will be worth about 45 in July 2026. The stock is currently trading at 41.13. This means that the stock has a potential upside of +9.34%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45 | 9.3% |